Kissei Pharmaceutical Reports Interim Ordinary Profit

Kissei Pharmaceutical reported consolidated ordinary profit of 29.23億円 for the interim period, compared with an ordinary loss of 56.22億円 a year earlier. It forecasts 44.00億円 for the fiscal year ending March.